Aldeyra Therapeutics News - ALDX

Company Name	Stock Ticker Symbol	Market	Type
Aldeyra Therapeutics Inc	ALDX	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	3.94	04:00:06

Open Price	Low Price	High Price	Close Price	Prev Close
				3.94

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	07:00	BW	Aldeyra Therapeutics Highlights Recent Preclinical Data in..
4/18/2024	07:00	BW	Aldeyra Therapeutics to Host Research & Development Day on..
3/28/2024	07:00	BW	Aldeyra Therapeutics Announces Clinical Development Plan for..
3/07/2024	16:54	EDGAR2	Form S-3 - Registration statement under Securities Act of..
3/07/2024	16:48	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
3/07/2024	16:40	EDGAR2	Form S-8 POS - Securities to be offered to employees in..
3/07/2024	16:06	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/06/2024	07:00	BW	Aldeyra Therapeutics to Participate in the Oppenheimer 34th..
1/29/2024	17:25	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
1/04/2024	07:00	EDGAR2	Form 8-K - Current report
1/04/2024	07:00	BW	Aldeyra Therapeutics Provides Clinical and Regulatory Update..
12/21/2023	16:06	EDGAR2	Form 8-K - Current report
12/19/2023	07:05	EDGAR2	Form 8-K - Current report
12/19/2023	07:00	BW	Aldeyra Therapeutics Announces Statistically and Clinically..
12/18/2023	16:01	BW	Aldeyra Therapeutics Schedules Conference Call and Webcast..
11/28/2023	07:16	EDGAR2	Form 8-K - Current report
11/27/2023	16:07	BW	Aldeyra Therapeutics Receives Complete Response Letter from..
11/03/2023	16:43	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
11/03/2023	16:08	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/01/2023	07:09	EDGAR2	Form 8-K - Current report
11/01/2023	07:05	BW	Aldeyra Therapeutics Enters into Exclusive Option Agreement..
10/16/2023	08:00	EDGAR2	Form 8-K - Current report
9/27/2023	05:45	PRNUS	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
9/26/2023	05:45	PRNUS	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
9/19/2023	05:45	PRNUS	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
9/12/2023	05:45	PRNUS	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
9/11/2023	17:42	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/29/2023	05:45	PRNUS	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
8/24/2023	16:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/22/2023	05:45	PRNUS	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
8/16/2023	05:45	PRNUS	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
8/11/2023	05:45	PRNUS	ALDX SHAREHOLDER ALERT: Jakubowitz Law Reminds Aldeyra..
8/09/2023	05:45	PRNUS	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
8/04/2023	05:45	PRNUS	ALDX SHAREHOLDER ALERT: Jakubowitz Law Reminds Aldeyra..
8/03/2023	16:03	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/06/2023	07:00	BW	Aldeyra Therapeutics to Participate in SVB Securities..
7/05/2023	17:42	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/05/2023	17:34	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/05/2023	17:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/03/2023	16:07	EDGAR2	Form 8-K - Current report
6/29/2023	16:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
6/29/2023	07:01	EDGAR2	Form 8-K - Current report
6/29/2023	07:00	BW	Aldeyra Therapeutics Announces Improvement from Baseline in..
6/28/2023	16:01	BW	Aldeyra Therapeutics Schedules Conference Call and Webcast..
6/27/2023	07:00	BW	Aldeyra Therapeutics Announces Statistically Significant..
6/26/2023	16:01	BW	Aldeyra Therapeutics Schedules Conference Call and Webcast..
6/23/2023	07:00	BW	Aldeyra Therapeutics to Join the Russell 2000® and Russell..
6/21/2023	09:34	BW	Aldeyra Therapeutics Provides Regulatory Update on ADX-2191
6/15/2023	07:00	BW	Aldeyra Therapeutics Announces Achievement of Statistical..
6/14/2023	16:01	BW	Aldeyra Therapeutics Schedules Conference Call and Webcast..